Aerovate Therapeutics, Inc.
INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF
Last updated:
Abstract:
The invention generally relates to inhalable formulations of imatinib, imatinib metabolites, imatinib salts, their manufacture, and uses thereof.
Status:
Application
Type:
Utility
Filling date:
14 May 2020
Issue date:
19 Nov 2020